EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic Metabolic Rewiring in a Mouse Model of Left Ventricular Hypertrophy

Alexandra V Schmidt iD, Tharika Thambidurai, Olivia D'Annibale, Sivakama S Bharathi iD, Tim Wood, Eric S Goetzman, Julian E Stelzer

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alexandra V Schmidt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Hypertrophy, Left Ventricular. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, American Heart Association-American Stroke Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Left ventricular hypertrophy (LVH) refers to the pathological thickening of the myocardial wall and is strongly associated with several adverse cardiac outcomes and sudden cardiac death. While the biomechanical drivers of LVH are well established, growing evidence points to a critical role for cardiac and systemic metabolism in modulating hypertrophic remodeling and disease pathogenesis. Despite the efficiency of fatty acid oxidation (FAO), LVH hearts preferentially increase glucose uptake and catabolism to drive glycolysis and oxidative phosphorylation (OXPHOS). The development of therapies to increase and enhance LFCA FAO is underway, with promising results. However, the mechanisms of systemic metabolic states and LCFA dynamics in the context of cardiac hypertrophy remain incompletely understood. Further, it is unknown to what extent cardiac metabolism is influenced by whole-body energy balance and lipid profiles, despite the common occurrence of lipotoxicity in LVH. In this study, we measured whole-body and cellular respiration along with analysis of lipid and glycogen stores in a mouse model of LVH. We found that loss of the cardiac-specific gene, myosin-binding protein C3 (Mybpc3), resulted in depletion of adipose tissue, decreased mitochondrial function in skeletal muscle, increased lipid accumulation in both the heart and liver, and loss of whole-body metabolic flux. We found that supplementation of exogenous LCFAs boosted LVH mitochondrial function and reversed cardiac lipid accumulation but did not fully reverse the hypertrophied heart nor systemic metabolic phenotypes. This study indicates that the LVH phenotype caused systemic metabolic rewiring in Mybpc3−/− mice and that exogenous LCFA supplementation boosted mitochondrial function in both cardiac and skeletal muscle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertrophy, Left VentricularAnimalsMiceDisease Models, AnimalLipid MetabolismFatty AcidsMyocardiumMaleEnergy MetabolismMice, Inbred C57BLMuscle, SkeletalMitochondriaMice, KnockoutOxidative Phosphorylation

Stichwörter der Autor:innen

cardiac lipotoxicitycardiac myosin-binding protein Cleft ventricular hypertrophylong-chain fatty acidsystemic metabolism

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Biochemical Genetics Laboratory, Children's Hospital of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Section of Clinical and Genetics Metabolism, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  • Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Department of Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15224, USA.

ORCID-Profile: Alexandra V Schmidt, Sivakama S Bharathi

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • American Heart Association-American Stroke Association
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Schmidt, A. V., Thambidurai, T., D'Annibale, O., Bharathi, S. S., Wood, T., Goetzman, E. S., & Stelzer, J. E. (2025). Systemic Metabolic Rewiring in a Mouse Model of Left Ventricular Hypertrophy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010111

Vancouver

Schmidt AV, Thambidurai T, D'Annibale O, Bharathi SS, Wood T, Goetzman ES, et al. Systemic Metabolic Rewiring in a Mouse Model of Left Ventricular Hypertrophy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010111

BibTeX
@article{Schmidt2025,
  author = {Schmidt, Alexandra V and Thambidurai, Tharika and D'Annibale, Olivia and Bharathi, Sivakama S and Wood, Tim and Goetzman, Eric S and Stelzer, Julian E},
  title = {Systemic Metabolic Rewiring in a Mouse Model of Left Ventricular Hypertrophy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010111}
}
Kostenlos starten →